Scott Genereux - 25 Feb 2026 Form 4 Insider Report for ROCKWELL AUTOMATION, INC (ROK)

Signature
Danielle White, Attorney-in-fact for Scott Genereux
Issuer symbol
ROK
Transactions as of
25 Feb 2026
Net transactions value
-$2,209,923
Form type
4
Filing time
27 Feb 2026, 16:24:33 UTC
Previous filing
10 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GENEREUX SCOTT Sr.VP, Chief Revenue Officer 1201 SOUTH SECOND STREET, MILWAUKEE Danielle White, Attorney-in-fact for Scott Genereux 27 Feb 2026 0001456171

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROK Common Stock Options Exercise $2,400,601 +6,844 +152% $350.76 11,358 25 Feb 2026 Direct
transaction ROK Common Stock Options Exercise $2,432,601 +9,363 +82% $259.81 20,721 25 Feb 2026 Direct
transaction ROK Common Stock Sale $1,183,145 -2,942 -14% $402.16 17,779 25 Feb 2026 Direct F1, F2
transaction ROK Common Stock Sale $1,041,616 -2,584 -15% $403.10 15,195 25 Feb 2026 Direct F1, F3
transaction ROK Common Stock Sale $1,965,029 -4,861 -32% $404.24 10,334 25 Feb 2026 Direct F1, F4
transaction ROK Common Stock Sale $1,580,943 -3,899 -38% $405.47 6,435 25 Feb 2026 Direct F1, F5
transaction ROK Common Stock Sale $561,269 -1,381 -21% $406.42 5,054 25 Feb 2026 Direct F1, F6
transaction ROK Common Stock Sale $187,240 -460 -9.1% $407.04 4,594 25 Feb 2026 Direct F1, F7
transaction ROK Common Stock Sale $32,640 -80 -1.7% $408.00 4,514 25 Feb 2026 Direct F1
transaction ROK Common Stock Sale $491,244 -1,200 -27% $409.37 3,314 25 Feb 2026 Direct F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROK Employee Stock Option (Right to Buy) Options Exercise $0 -6,844 -100% $0.000000 0 25 Feb 2026 Common Stock 6,844 $350.76 Direct F9
transaction ROK Employee Stock Option (Right to Buy) Options Exercise $0 -9,363 -97% $0.000000 300 25 Feb 2026 Common Stock 9,363 $259.81 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares exercised and sold pursuant to Rule 10b5-1 plan entered into on 11/26/2025.
F2 Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $401.6650 to $402.60. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
F3 Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $402.70 to $403.6850. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
F4 Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $403.7750 to $404.77. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
F5 Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $404.8250 to $405.7550. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
F6 Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $405.86 to $406.84. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
F7 Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $406.8650 to $407.66. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
F8 Sale of shares pursuant to Rule 10b5-1 plan entered into on 11/26/2025.
F9 The option vests in three substantially equal annual installments beginning on the date exercisable.